DC-SIGN (CD209), pentraxin 3 and vitamin D receptor gene variants associate with pulmonary tuberculosis risk in West Africans (original) (raw)

References

1. Ducati RG, Ruffino-Netto A, Basso LA, Santos DS . The resumption of consumption – a review on tuberculosis. Mem Inst Oswaldo Cruz 2006; 101: 697–714.
   Article CAS Google Scholar
2. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003; 163: 1009–1021.
   Article Google Scholar
3. Hill AV . Aspects of genetic susceptibility to human infectious diseases. Annu Rev Genet 2006; 40: 469–486.
   Article CAS Google Scholar
4. Tailleux L, Schwartz O, Herrmann JL, Pivert E, Jackson M, Amara A et al. DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. J Exp Med 2003; 197: 121–127.
   Article CAS Google Scholar
5. Barreiro LB, Neyrolles O, Babb CL, Tailleux L, Quach H, McElreavey K et al. Promoter variation in the DC-SIGN-encoding gene CD209 is associated with tuberculosis. PLoS Med 2006; 3: 0230–0235.
   Article CAS Google Scholar
6. Garlanda C, Bottazzi B, Bastone A, Mantovani A . Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol 2005; 23: 337–366.
   Article CAS Google Scholar
7. Vouret-Craviari V, Cenzuales S, Poli G, Mantovani A . Expression of monocyte chemotactic protein-3 in human monocytes exposed to the mycobacterial cell wall component lipoarabinomannan. Cytokine 1997; 9: 992–998.
   Article CAS Google Scholar
8. Vouret-Craviari V, Matteucci C, Peri G, Poli G, Introna M, Mantovani A . Expression of a long pentraxin, PTX3, by monocytes exposed to the mycobacterial cell wall component lipoarabinomannan. Infect Immun 1997; 65: 1345–1350.
   CAS PubMed PubMed Central Google Scholar
9. Azzurri A, Sow OY, Amedei A, Bah B, Diallo S, Peri G et al. IFN-gamma-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection. Microbes Infect 2005; 7: 1–8.
   Article CAS Google Scholar
10. Schroder NW, Schumann RR . Single nucleotide polymorphisms of toll-like receptors and susceptibility to infectious disease. Lancet Infect Dis 2005; 5 : 156–164.
    Article Google Scholar
11. Underhill DM, Ozinsky A, Smith KD, Aderem A . Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. Proc Natl Acad Sci USA 1999; 96: 14459–14463.
    Article CAS Google Scholar
12. Ben-Ali M, Barbouche MR, Bousnina S, Chabbou A, Dellagi K . Toll-like receptor 2 Arg677Trp polymorphism is associated with susceptibility to tuberculosis in Tunisian patients. Clin Diagn Lab Immunol 2004; 11: 625–626.
    CAS PubMed PubMed Central Google Scholar
13. Ogus AC, Yoldas B, Ozdemir T, Uguz A, Olcen S, Keser I et al. The Arg753GLn polymorphism of the human toll-like receptor 2 gene in tuberculosis disease. Eur Respir J 2004; 23: 219–223.
    Article CAS Google Scholar
14. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282: 2085–2088.
    Article CAS Google Scholar
15. Means TK, Wang S, Lien E, Yoshimura A, Golenbock DT, Fenton MJ . Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J Immunol 1999; 163: 3920–3927.
    CAS PubMed Google Scholar
16. Tsuji S, Matsumoto M, Takeuchi O, Akira S, Azuma I, Hayashi A et al. Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guerin: involvement of toll-like receptors. Infect Immun 2000; 68: 6883–6890.
    Article CAS Google Scholar
17. Means TK, Jones BW, Schromm AB, Shurtleff BA, Smith JA, Keane J et al. Differential effects of a toll-like receptor antagonist on _Mycobacterium tuberculosis_-induced macrophage responses. J Immunol 2001; 166: 4074–4082.
    Article CAS Google Scholar
18. Abel B, Thieblemont N, Quesniaux VJ, Brown N, Mpagi J, Miyake K et al. Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice. J Immunol 2002; 169: 3155–3162.
    Article CAS Google Scholar
19. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000; 25: 187–191.
    Article CAS Google Scholar
20. Newport MJ, Allen A, Awomoyi AA, Dunstan SJ, McKinney E, Marchant A et al. The toll-like receptor 4 Asp299Gly variant: no influence on LPS responsiveness or susceptibility to pulmonary tuberculosis in The Gambia. Tuberculosis (Edinb) 2004; 84: 347–352.
    Article CAS Google Scholar
21. Bafica A, Scanga CA, Feng CG, Leifer C, Cheever A, Sher A . TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis. J Exp Med 2005; 202: 1715–1724.
    Article CAS Google Scholar
22. Lazarus R, Klimecki WT, Raby BA, Vercelli D, Palmer LJ, Kwiatkowski DJ et al. Single-nucleotide polymorphisms in the toll-like receptor 9 gene (TLR9): frequencies, pairwise linkage disequilibrium, and haplotypes in three US ethnic groups and exploratory case-control disease association studies. Genomics 2003; 81: 85–91.
    Article CAS Google Scholar
23. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR et al. toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311: 1770–1773.
    Article CAS Google Scholar
24. Bornman L, Campbell SJ, Fielding K, Bah B, Sillah J, Gustafson P et al. Vitamin D receptor polymorphisms and susceptibility to tuberculosis in West Africa: a case-control and family study. J Infect Dis 2004; 190: 1631–1641.
    Article CAS Google Scholar
25. Sakuntabhai A, Turbpaiboon C, Casademont I, Chuansumrit A, Lowhnoo T, Kajaste-Rudnitski A et al. A variant in the CD209 promoter is associated with severity of dengue disease. Nat Genet 2005; 37: 507–513.
    Article CAS Google Scholar
26. Gomez LM, Anaya JM, Sierra-Filardi E, Cadena J, Corbi A, Martin J . Analysis of DC-SIGN (CD209) functional variants in patients with tuberculosis. Hum Immunol 2006; 67: 808–811.
    Article CAS Google Scholar
27. Aaby P, Bukh J, Lisse IM, Smits AJ . Measles mortality, state of nutrition, and family structure: a community study from Guinea-Bissau. J Infect Dis 1983; 147: 693–701.
    Article CAS Google Scholar
28. Gustafson P, Gomes VF, Vieira CS, Rabna P, Seng R, Johansson P et al. Tuberculosis in Bissau: incidence and risk factors in an urban community in sub-Saharan Africa. Int J Epidemiol 2004; 33: 163–172.
    Article Google Scholar
29. Harries A, Maher D, Graham S . Standardized tuberculosis case definitions and treatment categories. In: Harries A, Maher D, Graham S (eds). TB/HIV: A Clinical Manual, 2nd edn. WHO: Geneva, 2004, pp 105–109.
    Google Scholar
30. Sirugo G, Schim van der Loeff M, Sam O, Nyan O, Pinder M, Hill AV et al. A national DNA bank in The Gambia, West Africa, and genomic research in developing countries. Nat Genet 2004; 36: 785–786.
    Article CAS Google Scholar
31. Liu K, Muse SV . PowerMarker: an integrated analysis environment for genetic marker analysis. Bioinformatics 2005; 21: 2128–2129.
    Article CAS Google Scholar
32. Barrett JC, Fry B, Maller J, Daly MJ . Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263–265.
    Article CAS Google Scholar
33. Zaykin DV, Westfall PH, Young SS, Karnoub MA, Wagner MJ, Ehm MG . Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered 2002; 53: 79–91.
    Article Google Scholar
34. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B et al. The structure of haplotype blocks in the human genome. Science 2002; 296: 2225–2229.
    Article CAS Google Scholar
35. Ritchie MD, Hahn LW, Roodi N, Bailey LR, Dupont WD, Parl FF et al. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 2001; 69: 138–147.
    Article CAS Google Scholar
36. Hahn LW, Ritchie MD, Moore JH . Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 2003; 19: 376–382.
    Article CAS Google Scholar
37. Sanada H, Yatabe J, Midorikawa S, Hashimoto S, Watanabe T, Moore JH et al. Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension. Clin Chem 2006; 52: 352–360.
    Article CAS Google Scholar
38. Williams SM, Ritchie MD, Phillips III JA, Dawson E, Prince M, Dzhura E et al. Multilocus analysis of hypertension: a hierarchical approach. Hum Hered 2004; 57: 28–38.
    Article Google Scholar
39. Tsai CT, Lai LP, Lin JL, Chiang FT, Hwang JJ, Ritchie MD et al. Renin-angiotensin system gene polymorphisms and atrial fibrillation. Circulation 2004; 109: 1640–1646.
    Article CAS Google Scholar
40. Moore JH, Gilbert JC, Tsai CT, Chiang FT, Holden T, Barney N et al. A flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibility. J Theor Biol 2006; 241: 252–261.
    Article Google Scholar
41. Cho YM, Ritchie MD, Moore JH, Park JY, Lee KU, Shin HD et al. Multifactor-dimensionality reduction shows a two-locus interaction associated with type 2 diabetes mellitus. Diabetologia 2004; 47: 549–554.
    Article CAS Google Scholar
42. Brassat D, Motsinger AA, Caillier SJ, Erlich HA, Walker K, Steiner LL et al. Multifactor dimensionality reduction reveals gene-gene interactions associated with multiple sclerosis susceptibility in African Americans. Genes Immun 2006; 7: 310–315.
    Article CAS Google Scholar
43. Jakulin A, Bratko I . Analyzing attribute dependencies. In: N Lavrac DG, Blockeel H, Todorovski L (eds). 7th European Conference on Principles and Practice of Knowledge Discovery in Databases (PKDD 2003); 2003. Springer: Cavtat-Dubrovnik, Croatia, 2003, pp 229–240.
    Chapter Google Scholar
44. Jakulin A, Bratko I, Smrke D, Demsar J, Zupan B . Attribute Interactions in Medical Data Analysis. In: M Dojat EK, Barahona P (eds). 9th Conference on Artificial Intelligence in Medicine in Europe (AIME 2003). Springer: Protaras, Cyprus, 2003, pp 229–238.
    Google Scholar

Download references